Aurora Cannabis (ACB) EBITDA (2018 - 2025)
Historic EBITDA for Aurora Cannabis (ACB) over the last 8 years, with Q4 2025 value amounting to $13.3 million.
- Aurora Cannabis' EBITDA fell 452.81% to $13.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $77.4 million, marking a year-over-year increase of 19539.01%. This contributed to the annual value of $11.6 million for FY2025, which is 1548.01% down from last year.
- Per Aurora Cannabis' latest filing, its EBITDA stood at $13.3 million for Q4 2025, which was down 452.81% from $44.7 million recorded in Q3 2025.
- In the past 5 years, Aurora Cannabis' EBITDA registered a high of $58.1 million during Q1 2021, and its lowest value of -$489.0 million during Q2 2022.
- In the last 5 years, Aurora Cannabis' EBITDA had a median value of $2.9 million in 2024 and averaged -$19.9 million.
- In the last 5 years, Aurora Cannabis' EBITDA tumbled by 214082.17% in 2022 and then surged by 50130.04% in 2025.
- Aurora Cannabis' EBITDA (Quarter) stood at -$5.6 million in 2021, then skyrocketed by 118.65% to $1.1 million in 2022, then soared by 391.34% to $5.2 million in 2023, then skyrocketed by 168.57% to $13.9 million in 2024, then dropped by 4.53% to $13.3 million in 2025.
- Its last three reported values are $13.3 million in Q4 2025, $44.7 million for Q3 2025, and $7.8 million during Q2 2025.